High Wall Avenue analysts modified their outlook on these high names. For a whole view of all analyst ranking modifications, together with upgrades and downgrades, please see our analyst scores web page.
- B. Riley Securities minimize Ciena Company CIEN worth goal from $97 to $89. B. Riley Securities analyst Dave Kang maintained a Purchase ranking. Ciena shares closed at $63.95 on Tuesday. See how different analysts view this inventory.
- Truist Securities boosted the worth goal for Expedia Group, Inc. EXPE from $163 to $175. Truist Securities analyst Greg Miller maintained a Maintain ranking. Expedia shares closed at $163.75 on Tuesday. See how different analysts view this inventory.
- JP Morgan minimize Tesla, Inc. TSLA worth goal from $135 to $120. JP Morgan analyst Ryan Brinkman maintained an Underweight ranking. Tesla shares closed at $230.58 on Tuesday. See how different analysts view this inventory.
- Raymond James slashed the worth goal for Diamondback Vitality, Inc. FANG from $245 to $214. Raymond James analyst John Freeman maintained a Sturdy Purchase ranking. Diamondback Vitality shares closed at $144.65 on Tuesday. See how different analysts view this inventory.
- DA Davidson minimize the worth goal for RumbleOn, Inc. RMBL from $5 to $4. DA Davidson analyst Michael Baker maintained a Impartial ranking. RumbleOn shares closed at $3.59 on Tuesday. See how different analysts view this inventory.
- Susquehanna minimize Teradyne, Inc. TER worth goal from $165 to $155. Susquehanna analyst Mehdi Hosseini maintained a Constructive ranking. Teradyne shares settled at $87.07 on Tuesday. See how different analysts view this inventory.
- RBC Capital slashed Illumina, Inc. ILMN worth goal from $247 to $128. RBC Capital analyst Conor McNamara maintained an Outperform ranking. Illumina shares closed at $84.52 on Tuesday. See how different analysts view this inventory.
- Macquarie minimize Vail Resorts, Inc. MTN worth goal from $195 to $185. Macquarie analyst Paul Golding maintained a Impartial ranking. Vail Resorts shares closed at $165.42 on Tuesday. See how different analysts view this inventory.
- Wedbush minimize the worth goal for Arvinas, Inc. ARVN from $57 to $12. Wedbush analyst Robert Driscoll downgraded the inventory from Outperform to Impartial. Arvinas shares settled at $8.30 on Tuesday. See how different analysts view this inventory.
- Citigroup raised Core Laboratories Inc. CLB worth goal from $15 to $16. Citigroup analyst Scott Gruber upgraded the inventory from Promote to Impartial. Core Laboratories shares closed at $14.62 on Tuesday. See how different analysts view this inventory.
Learn This Subsequent:
Momentum2.82
Progress26.30
High quality–
Worth80.55
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
